Overview of Agranulocytosis - PowerPoint PPT Presentation

1 / 10
About This Presentation
Title:

Overview of Agranulocytosis

Description:

... Hematological Oncology. University Hospitals of Cleveland, ... Case Western Reserve University. Agranulocytosis. Drop in neutrophil count to less than 500/mm3 ... – PowerPoint PPT presentation

Number of Views:1167
Avg rating:3.0/5.0
Slides: 11
Provided by: fda
Category:

less

Transcript and Presenter's Notes

Title: Overview of Agranulocytosis


1
Overview of Agranulocytosis
  • Stan Gerson, MD
  • Chief, Division of Hematology Oncology
  • Asa Patricia Shiverick Professor of
    Hematological Oncology
  • University Hospitals of Cleveland,
  • Case Western Reserve University

2
Agranulocytosis
  • Drop in neutrophil count to less than 500/mm3
  • High incidence of neutropenic fever gt80
  • Duration of agranulocytosis directly impacts its
    severity and morbidity fever in 100 of patients
    after 5 days
  • Mortality is related to infections and their
    sequella
  • Rare in the absence of a serious illness or drug
    administration

3
(No Transcript)
4
Clozaril associated agranulocytosis
  • Serious disease in an affected individual
  • Represents a significant burden to health care
  • Early detection decreases risk

5
(No Transcript)
6
Key features of clozapine associated
agranulocytosis
  • Onset in 1-3 weeks - detected by monitoring
  • Rapid onset is more severe
  • Benefit from early detection, drug is stopped
    prior to onset of symptoms
  • Often the drug is stopped with a WBC of 2000-3000
    and an ANC of 300-1000
  • Unique features
  • Severe drop in granulocyte count to 0 even
    after the drug is stopped
  • Prolonged duration 8d with growth factors, 15 d
    without
  • Significant risk of neutropenic fever, severe
    internal infection

7
(No Transcript)
8
Management of agranulocytosis
  • Hospitalization of patient is recommended
  • Daily observation for fever, infection culture
    and image of possible sites of infection
  • Antibiotics - either prophylactic or for fever
  • Hematopoietic growth factors G-CSF, GM-CSF
  • Duration of illness - 8-25 days
  • Substantial cost for treatment hospitalization,
    antibiotics and growth factors

9
Advantages of monitoring system
  • Early detection prior to symptoms
  • Stop the drug early
  • Early initiation of treatment and management of
    agranulocytosis
  • Reassurance to patient, family and health care
    providers

10
Conclusions
  • Clozaril associated agranulocytosis is a serious
    illness
  • Monitoring allows detection prior to illness
  • Early detection can limit morbidity by prompt
    institution of management
  • Management is costly
Write a Comment
User Comments (0)
About PowerShow.com